insights_auto
Why is ARGX down 4.09%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
€ 727.60
arrow_downward
-4.09%(-31.00) 1D
10-р сарын 16, 17:39:35 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€ 759.20
High
€ 761.80
Low
€ 727.60
Mkt. cap
48.36 тэрбум
Avg. vol.
86.90 мян
Volume
96.25 мян
P/E ratio
30.95
52-wk high
€ 925.00
52-wk low
€ 568.40
EPS
€ 23.51
Shares outstanding
35.93 сая
No. of employees
2 мян
Open
€ 759.20
High
€ 761.80
Low
€ 727.60
Mkt. cap
48.36 тэрбум
Avg. vol.
86.90 мян
Volume
96.25 мян
P/E ratio
30.95
52-wk high
€ 925.00
52-wk low
€ 568.40
EPS
€ 23.51
Shares outstanding
35.93 сая
No. of employees
2 мян
News stories
From web sources and news partners
TipRanks
·
4 цагийн өмнө
Argenx Stock Stumbles As Trial Failure Haunts Rally
ad-hoc-news.de
·
13 цагийн өмнө
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
15 цагийн өмнө
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
ad-hoc-news.de
·
17 цагийн өмнө
argenx sets October 22 results date as Argenx stock costs EUR 761.20
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE